344 results on '"Pettitt, A R"'
Search Results
2. Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
3. Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features
4. Is it time for PET-guided therapy in follicular lymphoma?
5. Patient and health practitioner views and experiences of a cancer trial before and during COVID-19: qualitative study
6. Self-consistent modelling of the Milky Way structure using live potentials.
7. The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab
8. Hypertension and cardiovascular risk factors when treating cancer patients: underrecognised and undertreated
9. Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells
10. Biochar incorporation increased nitrogen and carbon retention in a waste-derived soil
11. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
12. JASMINE: Near-infrared astrometry and time-series photometry science.
13. The impact of bar origin and morphology on stellar migration.
14. Cell survival, P53 dysfunction and nucleoside action in chronic lymphocytic leukaemia
15. Does carbon limitation reduce nitrogen retention in soil?
16. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
17. Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia
18. Star cluster formation and feedback in different environments of a Milky Way-like galaxy.
19. Massive core/star formation triggered by cloud–cloud collision – II. High-speed collisions of magnetized clouds.
20. CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia
21. An Investigation of Some Critical Physico-chemical Parameters Influencing the Operational Rotary In-vessel Composting of Food Waste by a Small-to-Medium Sized Enterprise
22. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
23. EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era
24. Supplement to: Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
25. Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk
26. Variation in microbial communities colonizing horticultural slow sand filter beds: implications for filter function
27. Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL
28. Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
29. Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach
30. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia
31. Pharmacogenetics in the treatment of chronic lymphocytic leukemia: what does the future hold?
32. Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
33. Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells
34. COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis.
35. The role of prognostic factors in assessing ‘high-risk’ subgroups of patients with chronic lymphocytic leukemia
36. Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects
37. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia
38. PLCγ is enriched on poly-phosphoinositide-rich vesicles to control nuclear envelope assembly
39. The changing GMC population in galaxy interactions
40. Stable adhesion and migration of human neutrophils requires phospholipase D-mediated activation of the integrin CD11b/CD18
41. Lipidomic Analysis of Signaling Pathways
42. Basic fibroblast growth factor suppresses p53 activation in the neoplastic cells of a proportion of patients with chronic lymphocytic leukaemia
43. Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance
44. The ATR-p53 pathway is suppressed in noncycling normal and malignant lymphocytes
45. Chemokine unresponsiveness of chronic lymphocytic leukaemia cells results from impaired endosomal recycling of Rap1 and is associated with a distinctive type of immunological anergy: 41
46. Pharmacogenetic analysis of CYP2B6 in the LRF CLL4 trial: the *6 allelic variant is associated with inferior efficacy following fludarabine plus cyclophosphamide: 39
47. The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17p
48. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathway
49. Analysis of intact phosphoinositides in biological samples
50. Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.